Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...

Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...

Two more drug-making giants will officially start selling popular commercial medications on the White House's discounted pharmaceutical site as soon as Monday, CBS News exclusively learned. American ...

The Samsung Galaxy S26 Ultra’s S Pen is more than just a stylus; it’s a versatile tool designed to enhance productivity, creativity, and overall device interaction. Whether you’re a professional ...

If you’re ready for a clearer, more efficient approach to getting stronger, Build Muscle, Lose Fat: The Body Recomp Guide will walk you through exactly what to do. It breaks down how to train, eat, ...

The product is priced at 95% below the brand-name cost. Ease of adoption. The product is FDA-designated as interchangeable and supported by innovative prescriber and patient engagement programs to ...

We get it: Cooking meals with all the right stuff can be time-consuming and feel overwhelming. Especially when you're trying to pack those meals with critical nutrients for women, like protein and ...

(RTTNews) - Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, said its Adalimumab Injection 9MW0113, marketed as JUNMAIKANG in China, has ...

Humira is a brand-name drug prescribed to treat rheumatoid arthritis, psoriatic arthritis, and more. It can remain unrefrigerated for up to 14 days, as long as the temperature doesn’t go above 77°F ...

The biosimilar Hyrimoz showed similar flare rates to Humira, but 25% of patients experienced adverse events, mainly injection site reactions. Injection pain, linked to Hyrimoz's citrate content and ...

Amjevita and Imraldi, two biosimilar agents for adalimumab (Humira), were just as effective in treating psoriasis as the original drug for both new users and patients who switched from adalimumab to ...